Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Asia
Pharma
Licensing deals, AI pact and Novo vs. KBP—Fierce Pharma Asia
Dianthus and Boehringer headlined the latest round of licensing deals featuring China biotechs. Takeda inked its second pact with Nabla Bio. And more.
Eric Sagonowsky
Oct 17, 2025 9:40am
Trump's pharma tariffs offer some relief, many unknowns
Sep 26, 2025 11:16am
J&J coins the term '3rd opinion' to empower lung cancer patients
Aug 1, 2025 10:38am
Marubeni grabs Sumitomo's Asia pharma business in $480M deal
Apr 2, 2025 11:30am
Klick buys Ward6 Singapore’s operations to fuel Asian expansion
Mar 17, 2025 6:00pm
Bain Capital lays out $3.3B to acquire Mitsubishi Tanabe Pharma
Feb 7, 2025 11:26am